Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (302)	9/11/2002 7:29:09 PM
From: mopgcw	Read Replies (1) \| Respond to of 3661

"It seems to be finding support at the $0.55 level.." If only my basis wasn't $2....alas, at least my ntii is offsetting it somewhat... so the question is, since I was originally a believer in somatokine and buyer of ctrx at $2, should I triple down here to book the tax loss, maintain the position and ride it up as somatokine hits the targets??? been doing this strategy a little too much lately...c'mon tlrk.... thanks for the references. george